Publication:

Bibliometric analysis on the publications of the statins-associated autoimmune myopathy: a comprehensive review

This bibliometric analysis aimed to assess the landscape of research on statin-associated autoimmune myopathy (SAAM), focusing on publication trends, contributors, and implications for further investigation. Access to the Scopus and Web of Science databases was obtained through institutional login credentials. An advanced search using keywords "statin associated autoimmune myopathy" or "SAAM" was conducted. Data were collected from 2003 to 2022 and analysed using the Biblioshiny package in R-Studio. A total of 110 publications were identified, involving 418 authors. The analysis revealed a steady increase in publication activity on SAAM, particularly notable in 2017, 2020, 2021, and 2022, with a peak of 13 publications in certain years. However, no publications were recorded in 2014. The accumulated citations from 2003 to 2022 totalled approximately 3,000, indicating a sustained interest in the topic. Statins, being first-line drugs for conditions like hyperlipidemia, diabetes mellitus, cardiovascular diseases, obesity, and cancer, underscore the importance of vigilant monitoring for associated adverse events. The analysis highlights the need for further research on SAAM, a drug-related adverse reaction, due to the widespread use of statins and their association with comorbidities. Understanding and monitoring SAAM is crucial for patient safety, and further investigation is needed to understand its mechanisms and risk factors.